Voting Results of 18th AGM: All Resolutions Passed with Requisite Majority
The passing of resolutions at the AGM ensures the smooth functioning of the company and its governance, having a moderate impact.
All resolutions were passed with the required majority, indicating a positive outcome for the company.
* Acutaas Chemicals Limited held its 18th Annual General Meeting (AGM) on September 25, 2025, via video conferencing. * Mr. Kashyap Shah of M/s. Kashyap Shah & Co. served as the scrutinizer. * All resolutions outlined in the AGM notice were duly passed with the required majority. * The resolutions included: * Adoption of the audited financial statements for the year ended March 31, 2025. * Declaration of final dividend for the financial year 2024-25. * Re-appointment of Mr. Nareshkumar Ramjibhai Patel as a director. * Ratification of remuneration of Cost Auditors for financial year 2025-26. * Reappointment of Mr. Nareshkumar Ramjibhai Patel as Executive Chairman & Managing Director and approval of payment of remuneration. * Reappointment of Mr. Chetankumar Chhaganlal Vaghasia as the Whole Time Director of Company and approval of payment of remuneration. * Reappointment of Mr. Virendra Nath Mishra as the Whole Time Director of Company and approval of payment of remuneration. * Re-appointment of Mrs. Richa Manoj Goyal as Director (Non-Executive & Independent) of the company for second term of five years. * Re-appointment of Mr. Hetal Madhukant Gandhi as Director (Non-Executive & Independent) of the company for second term of five years. * Approval for payment of commission to Non - Executive Directors of the Company. * Appointment of M/s KSPS & Co. LLP as the Secretarial Auditors of Company. * Voting was conducted through remote e-voting and e-voting during the AGM. * The voting results and Scrutinizer’s Report are available on the company's website.
What to do with a filing like this
Acutaas Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under agm-egm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Acutaas Chemicals Limited. Read the original for the full detail.